Abstract：【Objective】 To explore the clinical efficacy of combination of ritodrine hydrochloride tablets and dexamethasone in the treatment of recurrent miscarriage patients.【Methods】A total of 88 patients with recurrent miscarriage admitted to Yan'an University Affiliated Hospital from January 2019 to December 2022 were randomly divided into a control group and an observation group, with 44 cases in each group. The control group was treated with ritodrine hydrochloride tablets, while the observation group was treated with dydrogesterone on the basis of the control group. Both groups received fetal protection treatment until the 70th day of pregnancy. We compared the clinical efficacy, incidence of adverse reactions during treatment, heart rate, blood pressure, progesterone (P), estradiol (E2), and soluble leukocyte antigen G (sHLA-G) levels before and after treatment between two groups.【Results】The total effective rate of the observation group was 93.18%, significantly higher than the control group's 72.73% (P<0.05). After treatment, the blood pressure and heart rate of both groups of patients decreased (P<0.05), and the heart rate and blood pressure of the observation group were lower than those of the control group (P<0.05). After treatment, the serum E2, P, and sHLA-G levels in both groups of patients decreased (P<0.05), and the serum E2, P, and sHLA-G levels in the observation group were on average lower than those in the control group (P<0.05). The total incidence of adverse reactions during treatment in the observation group was lower than that in the control group (P<0.05). 【Conclusion】 The combination of ritodrine hydrochloride tablets and dydrogesterone has a significant effect on the treatment of recurrent miscarriage patients, which can reduce E2 and P levels, reduce the incidence of adverse reactions, and is worthy of clinical promotion and application.
赵子英, 罗婧, 俞梦春. 盐酸利托君片联合地屈孕酮治疗反复性流产患者的临床疗效[J]. 医学临床研究, 2023, 40(10): 1456-1458.
ZHAO Ziying, LUO Jing, YU Mengchun. The Clinical Efficacy of Ritodrine Hydrochloride Tablets Combined with Dydrogesterone in the Treatment of Recurrent Miscarriage Patients. JOURNAL OF CLINICAL RESEARCH, 2023, 40(10): 1456-1458.
2023, Vol. 40 
